Considerations for Treatment of PSMA-Staged High-Risk Patients in Community Practice
![](https://academy.astro.org/sites/default/files/styles/course_image_teaser/public/OnlineCourses.jpg?itok=VNNiGZcY)
This activity discusses the use of PSMA PET for staging in high-risk prostate cancer. This includes when to order a PSMA PET, how to interpret it, common pitfalls and controversies of the scans.
Category
- Other
- Genitourinary Cancer
Format
- CME only
Credits
- 1.25 AMA PRA Category 1 Credit™
- 1.25 Certificate of Attendance
Gray Zone - Selecting the Right Tool For the Job: Contemporary Treatment of Localized Renal Cell Carcinoma
![](https://academy.astro.org/sites/default/files/styles/course_image_teaser/public/GrayZone_Single.jpg?itok=CYl44mSO)
The ultimate goal of radiation oncology research is to improve clinical care. As a specialty, we tackle diverse research questions, addressing every type of cancer and encompassing cancer biology and radiation physics. But despite our best efforts, evidence-based medicine cannot provide 1 clear
Category
- Genitourinary Cancer
Format
- Gray Zone
Credits
- 1.00 AMA PRA Category 1 Credit™
Gray Zone - Ignorance is Bliss? A Case of Incidental Discovery of ATM Mutation in Prostate Cancer
![](https://academy.astro.org/sites/default/files/styles/course_image_teaser/public/GrayZone_Single.jpg?itok=CYl44mSO)
The ultimate goal of radiation oncology research is to improve clinical care. As a specialty, we tackle diverse research questions, addressing every type of cancer and encompassing cancer biology and radiation physics. But despite our best efforts, evidence-based medicine cannot provide 1 clear
Category
- Genitourinary Cancer
Format
- Gray Zone
Credits
- 1.00 AMA PRA Category 1 Credit™
Advancement in Imaging for Radiation Oncology
![](https://academy.astro.org/sites/default/files/styles/course_image_teaser/public/OnlineCourses.jpg?itok=VNNiGZcY)
Various advances in imaging are changing the clinical practice for Radiation Oncology.
Category
- Other
- Physics
- Genitourinary Cancer
Format
- CME only
Credits
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Certificate of Attendance
Combined Modality Therapy for Lymph Node Positive Prostate Cancer
![](https://academy.astro.org/sites/default/files/styles/course_image_teaser/public/OnlineCourses.jpg?itok=VNNiGZcY)
Historically, the management of lymph node positive prostate cancer was limited to androgen deprivation therapy, but increasing data now support the use of multimodality therapy. As treatment options have expanded, patient-centered decision making has become increasingly complicated.
Category
- Genitourinary Cancer
Format
- CME only
Credits
- 1.25 AMA PRA Category 1 Credit™
- 1.25 Certificate of Attendance